Inhaled Voriconazole For Prevention Of Invasive Pulmonary Aspergillosis
dc.contributor.utaustinauthor | Tolman, Justin A. | en |
dc.contributor.utaustinauthor | Wiederhold, Nathan P. | en |
dc.contributor.utaustinauthor | McConville, Jason T. | en |
dc.contributor.utaustinauthor | Williams, Robert O. | en |
dc.creator | Tolman, Justin A. | en |
dc.creator | Wiederhold, Nathan P. | en |
dc.creator | McConville, Jason T. | en |
dc.creator | Najvar, Laura K. | en |
dc.creator | Bocanegra, Rosie | en |
dc.creator | Peters, Jay I. | en |
dc.creator | Coalson, Jacqueline J. | en |
dc.creator | Graybill, John R. | en |
dc.creator | Patterson, Thomas F. | en |
dc.creator | Williams, Robert O. | en |
dc.date.accessioned | 2015-09-09T15:51:00Z | en |
dc.date.available | 2015-09-09T15:51:00Z | en |
dc.date.issued | 2009-06 | en |
dc.description.abstract | Targeted airway delivery of antifungals as prophylaxis against invasive aspergillosis may lead to high lung drug concentrations while avoiding toxicities associated with systemically administered agents. We evaluated the effectiveness of aerosolizing the intravenous formulation of voriconazole as prophylaxis against invasive pulmonary aspergillosis caused by Aspergillus fumigatus in an established murine model. Inhaled voriconazole significantly improved survival and limited the extent of invasive disease, as assessed by histopathology, compared to control and amphotericin B treatments. | en |
dc.description.department | Pharmaceutical Sciences | en |
dc.description.sponsorship | en | |
dc.identifier.citation | Tolman, J. A., Wiederhold, N. P., McConville, J. T., Najvar, L. K., Bocanegra, R., Peters, J. I., Williams, R. O. (Jun., 2009). Inhaled Voriconazole for Prevention of Invasive Pulmonary Aspergillosis. Antimicrobial Agents and Chemotherapy, 53(6), 2613–2615. doi:10.1128/AAC.01657-08 | en |
dc.identifier.doi | 10.1128/aac.01657-08 | en |
dc.identifier.issn | 0066-4804 | en |
dc.identifier.uri | http://hdl.handle.net/2152/31157 | en |
dc.identifier.url | en | |
dc.language.iso | English | en |
dc.relation.ispartofserial | Antimicrobial Agents and Chemotherapy | en |
dc.rights | Administrative deposit of works to Texas ScholarWorks: This works author(s) is or was a University faculty member, student or staff member; this article is already available through open access or the publisher allows a PDF version of the article to be freely posted online. The library makes the deposit as a matter of fair use (for scholarly, educational, and research purposes), and to preserve the work and further secure public access to the works of the University. | en |
dc.rights.holder | en | |
dc.subject | murine model | en |
dc.subject | amphotericin-b | en |
dc.subject | transplantation | en |
dc.subject | burden | en |
dc.subject | microbiology | en |
dc.subject | pharmacology & pharmacy | en |
dc.title | Inhaled Voriconazole For Prevention Of Invasive Pulmonary Aspergillosis | en |
dc.type | Article | en |
Access full-text files
Original bundle
1 - 1 of 1